Spruce Biosciences, Inc. Common Stock (SPRB) — Financial Flexibility Index
Spruce Biosciences, Inc. Common Stock (SPRB) has a Financial Flexibility Index of -0.61x as of December 2025. Free cash flow of $-6.46 Million (operating CF $-6.46 Million minus capex $0.00) represents -1% of total liabilities ($10.51 Million). Check Spruce Biosciences, Inc. Common Stock (SPRB) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Spruce Biosciences, Inc. Common Stock Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Spruce Biosciences, Inc. Common Stock across 8 annual periods. See Spruce Biosciences, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Spruce Biosciences, Inc. Common Stock (2018–2025)
Year-by-year free cash flow to debt coverage for Spruce Biosciences, Inc. Common Stock. For the full company profile including market capitalisation, see Spruce Biosciences, Inc. Common Stock (SPRB) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.17x | $-33.33 Million | $-33.33 Million | $10.51 Million | ▲ +7.1% |
| 2024 | -3.41x | $-55.96 Million | $-55.96 Million | $16.39 Million | ▼ -181.6% |
| 2023 | -1.21x | $-33.27 Million | $-33.27 Million | $27.44 Million | ▲ +50.1% |
| 2022 | -2.43x | $-41.67 Million | $-41.68 Million | $17.16 Million | ▼ -2.6% |
| 2021 | -2.37x | $-35.78 Million | $-35.88 Million | $15.12 Million | ▼ -16.1% |
| 2020 | -2.04x | $-27.45 Million | $-27.52 Million | $13.46 Million | ▼ -471.3% |
| 2019 | -0.36x | $-12.61 Million | $-12.62 Million | $35.33 Million | ▲ +5.9% |
| 2018 | -0.38x | $-8.57 Million | $-8.57 Million | $22.58 Million | — |